Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Derma Sciences, Inc. (DSCI) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

Derma Sciences is a medical technology company with its focus on advanced wound care. The company currently targets three segments of the wound care marketplace: pharmaceutical wound care products; advanced wound care dressings addressing chronic wounds, including diabetic ulcers; and traditional dressings. Based on excellent Phase 2 data, the company has commenced Phase 3 clinical trials in diabetic foot ulcer healing with DSC127. Other novel products include the company’s MEDIHONEY product, TCC-EZ, XTRASORB and BIOGUARD. For more information, visit the company’s Web site: http://www.dermasciences.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *